Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Healthcare Medical Devices
DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:ADK)

DIAGNOS Announces Closing of Private Placement and Exercise of Stock Warrants

GlobeNewswire May 18, 2023

DIAGNOS and IRIS, The Visual Group strengthen partnership with the launch of "IRIS-ai powered by DIAGNOS"

GlobeNewswire May 17, 2023

DIAGNOS and ÉTS Unveil a Method to Adapt Deep Learning Algorithms According to the Diversity of Contexts

GlobeNewswire February 28, 2023

DIAGNOS and ETS to Present Ground-breaking Research on Mass Screening for Macular Edema at ARVO 2023

GlobeNewswire February 14, 2023

DIAGNOS Announces Grant of Stock Options

GlobeNewswire February 10, 2023

DIAGNOS Gets the Green Light for the Use of its Diabetic Retinopathy Screening Technology in Quebec Hospitals

GlobeNewswire January 31, 2023

DIAGNOS (TSXV:ADK) closes $250K financing

Caroline Egan  January 13, 2023

DIAGNOS Announces Closing of Private Placement

GlobeNewswire January 13, 2023

DIAGNOS Provides Additional Information to the Closing of Private Placement

GlobeNewswire December 15, 2022
View More News ››

Opinion & Analysis (TSXV:ADK)

Diagnos increases footprint, and endorsements mount for AI tech that averts illness

Stockhouse Editorial June 4, 2020

DIAGNOS poised for parabolic move as first of new cardio AI Applications comes to market

Stockhouse Editorial May 5, 2020

DIAGNOS Inc. expands artificial intelligence platform, first mover in $386 billion/yr market

Stockhouse Editorial September 21, 2017

DIAGNOS Inc. adoption curve to accelerate applying AI in healthcare

Stockhouse Editorial May 31, 2017

DIAGNOS applying artificial intelligence in diabetes market, vertical growth trajectory in sight

Stockhouse Editorial December 2, 2016
View More Opinion ››

Bullboard Posts (TSXV:ADK)

ADK slowly on its way to $1

Company snapshot Powered by Morningstar & Refinitiv ADK is up 147.6% for the last...
BLUEBERRY5 - August 28, 2023

Numbers are out....

Looks like we'll need another PP. https://www.sedarplus.ca/csa-party/viewInstance/view.html?id...
hotginger - August 25, 2023

RE:RE:RE:Q4 is out...

Agreed! Horrible financials. I am hopeful that this Iris deal is moving forward. we need some great news.
hotginger - July 14, 2023

RE:RE:Q4 is out...

horrible financials as expected.  the recent buying and sp increase is from some heavy irons in the fire.  big things happening...
Joey111 - July 14, 2023

RE:Q4 is out...

Revenue and net loss horrible what the F__k
slipdan - July 13, 2023

Q4 is out...

https://www.diagnos.com/wp-content/uploads/2023/07/DIAGNOS-2023-Audited-Financial-Statements.pdf
hotginger - July 13, 2023
View more Bullboard ››

Acceleware Ltd

Acceleware Ltd

Acceleware Ltd. is a Canada-based company that develops clean-tech decarbonization technologies. The Company has two business ...
View More »